✦ LIBER ✦

Palivizumab's value for RSV prophylaxis in high-risk infants varies

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Palivizumab's value for RSV prophylaxis

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 121 KB

Palivizumab for RSV prophylaxis cost eff

📂 Article 📅 1999 🏛 Adis International Limited (now part of Wolters Kl ⚖ 426 KB

Palivizumab for respiratory syncytial vi

✍ Jennifer H. Lofland; Suzanne M. Touch; John P. O'Connor; Mary Lou Chatterton; El 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 890 KB

Cost-Effectiveness Analysis of Palivizum

✍ Langenfeld, M.K.; Visser, S. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Palivizumab worth it for high-risk infan

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 121 KB

Palivizumab worth it for high-risk infan

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 118 KB